Matching slides 78,129
Current window 18,151-18,180
Pages 2,605
Rows per page 30
Component: Chartclear collectionreset all

Component

18,151-18,180 of 78,129

filter-aware
12
Slide includes two charts: a stacked bar chart for sales growth and a stacked bar chart for collaboration revenue.AstraZeneca | Results Presentation Deck | 42 slides · AstraZeneca
Conference presentation Investor relations Beat · SatisfactionLoop · Pattern Hunter2 hits
13
Includes footnotes detailing specific market segments (CLL, MCL, mBC, mGC) and data sources.AstraZeneca | Results Presentation Deck | 42 slides · AstraZeneca
Conference presentation Investor relations Beat · SatisfactionLoop · Pattern Hunter2 hits
15
The slide uses stacked bar charts to show revenue composition over time from Q1 2018 to Q2 2021.AstraZeneca | Results Presentation Deck | 42 slides · AstraZeneca
Conference presentation Investor relations Beat · Satisfaction2 hits
23
The slide uses a stacked bar chart for profit mix and a waterfall chart for net debt bridge.AstraZeneca | Results Presentation Deck | 42 slides · AstraZeneca
Conference presentation Investor relations Beat · Action2 hits
28
The slide uses Kaplan-Meier survival curves to demonstrate efficacy in two major Phase III trials.AstraZeneca | Results Presentation Deck | 42 slides · AstraZeneca
Conference presentation Investor relations Beat · ActionLoop · Cost Of Inaction2 hits
32
The slide outlines a strategic approach to member outreach, emphasizing segmentation and testing, with a specific case study on penetration rates.Babylon | SPAC Presentation Deck | 100 slides · Babylon
Conference presentation Investment bank 2 hits
79
The slide uses two identical bridge charts to illustrate the impact of contract conversion on revenue projections for 2021 and 2022.Babylon | SPAC Presentation Deck | 100 slides · Babylon
Conference presentation Investment bank Beat · Financials2 hits
04
Dual-axis charts showing absolute dollar values (bars) and percentage/per-share metrics (lines).BlackRock | Results Presentation Deck | 11 slides · BlackRock
Conference presentation Investor relations Beat · Financial Performance2 hits
05
The slide uses a combination of bar charts for dollar amounts and a line/data series for share counts.BlackRock | Results Presentation Deck | 11 slides · BlackRock
Conference presentation Investor relations Beat · Financial Performance2 hits
08
The slide uses two waterfall charts to bridge revenue figures across different time periods.BlackRock | Results Presentation Deck | 11 slides · BlackRock
Conference presentation Investor relations Beat · Future Outlook2 hits
03
The slide uses a waterfall-style bar chart to rank transactions by valuation multiples.BMO Capital Markets | Investment Banking Pitch Book | 6 slides · BMO Capital Markets
Consulting deck Investment bank Beat · Evidence & ProofLoop · Benchmark Gap2 hits
09
The slide highlights diversification across multiple real estate sectors and investment strategies.Bridge Investment Group | IPO Presentation Deck | 29 slides · Bridge Investment Group
Pitch deck Investment bank Beat · Market Size2 hits
12
The slide uses two pie charts to visualize revenue composition and AUM duration.Bridge Investment Group | IPO Presentation Deck | 29 slides · Bridge Investment Group
Pitch deck Investment bank 2 hits
20
Bridge Investment Group | IPO Presentation Deck | 29 slidesBridge Investment Group | IPO Presentation Deck | 29 slides · Bridge Investment Group
Pitch deck Investment bank Beat · Why NowLoop · Cost Of Inaction2 hits
31
Kaplan-Meier survival curves showing superior efficacy of CB-011.Caribou Biosciences | IPO Presentation Deck | 44 slides · Caribou Biosciences
Pitch deck Investment bank Beat · Traction2 hits
07
Central Pacific Financial | Results Presentation Deck | 13 slidesCentral Pacific Financial | Results Presentation Deck | 13 slides · Central Pacific Financial
Conference presentation Investor relations Beat · Desire2 hits
19
Data shows efficacy of ERAS-007 in combination with Encorafenib and Cetuximab in BRAF-mutant colorectal cancer models.Erasca | IPO Presentation Deck | 46 slides · Erasca
Pitch deck Investment bank Beat · Traction2 hits
20
The slide demonstrates efficacy in two distinct models (HCC827/ER1 and NCI-H820).Erasca | IPO Presentation Deck | 46 slides · Erasca
Pitch deck Investment bank Beat · Traction2 hits
21
The slide presents preclinical efficacy data for ERAS-007 in two different KRAS-mutant cancer models.Erasca | IPO Presentation Deck | 46 slides · Erasca
Pitch deck Investment bank Beat · Traction2 hits
31
IC50 values represent potency; lower values indicate higher potency.Erasca | IPO Presentation Deck | 46 slides · Erasca
Pitch deck Investment bank 2 hits
33
TGI = Tumor Growth Inhibition. Data shows mean tumor volume over time.Erasca | IPO Presentation Deck | 46 slides · Erasca
Pitch deck Investment bank 2 hits
34
NSCLC EGFR exon 19 deletion CDX model HCC827Erasca | IPO Presentation Deck | 46 slides · Erasca
Pitch deck Investment bank 2 hits
35
CRC KRAS G12C PDX CO-04-0310 model used for efficacy and safety assessment.Erasca | IPO Presentation Deck | 46 slides · Erasca
Pitch deck Investment bank 2 hits
40
TGI = Tumor Growth Inhibition. CDX = Cell line-derived xenograft. MIA PaCa-2 is a human pancreatic cancer cell line.Erasca | IPO Presentation Deck | 46 slides · Erasca
Pitch deck Investment bank 2 hits
41
The slide presents preclinical efficacy and safety data for the lead candidate ERAS-3490.Erasca | IPO Presentation Deck | 46 slides · Erasca
Pitch deck Investment bank 2 hits
19
The slide uses a combination of bar charts to show current vs. potential scale and a checklist for strategic initiatives.European Wax Center | IPO Presentation Deck | 34 slides · European Wax Center
Pitch deck Investment bank 2 hits
25
Includes a footnote regarding the definition of system-wide sales.European Wax Center | IPO Presentation Deck | 34 slides · European Wax Center
Pitch deck Investment bank Beat · Financials2 hits
09
Slide 9 of a presentation; highlights core funding and market positioning.Independent Bank Corp | Results Presentation Deck | 27 slides · Independent Bank Corporation
Conference presentation Investor relations Beat · Need2 hits
11
Includes a pie chart for composition, a combo chart for yield/volume, and bulleted highlights.Independent Bank Corp | Results Presentation Deck | 27 slides · Independent Bank Corporation
Conference presentation Investor relations Beat · SatisfactionLoop · Cost Of Inaction2 hits
14
The slide provides a detailed segmentation of a $1.245 billion commercial loan portfolio, split between C&I/owner-occupied ($823M) and investment real estate ($422M).Independent Bank Corp | Results Presentation Deck | 27 slides · Independent Bank Corporation
Conference presentation Investor relations Beat · SatisfactionLoop · Cost Of Inaction2 hits